Search Results - "Sarmiento, U. Bohn"

Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study) by Perez-Fidalgo, J.A., Cortés, A., Guerra, E., García, Y., Iglesias, M., Bohn Sarmiento, U., Calvo García, E., Manso Sánchez, L., Santaballa, A., Oaknin, A., Redondo, A., Rubio, M.J., González-Martín, A.

“…There is limited evidence for the benefit of olaparib in platinum-resistant ovarian cancer (PROC) patients with BRCA wild-type tumors. This study investigated…”
Get full text

Assessment of renal toxicity and osteonecrosis of the jaws in patients receiving zoledronic acid for bone metastasis by Aguiar Bujanda, D, Bohn Sarmiento, U, Cabrera Suárez, MÁ, Aguiar Morales, J

“…Background: Bisphosphonates (BP) decrease the incidence of skeletal related events among cancer patients with bone metastases from solid tumors and multiple…”
Get full text

Successful recovery after accidental overdose of cyclophosphamide by Aguiar Bujanda, D., Cabrera Suárez, M. Á., Bohn Sarmiento, U., Aguiar Morales, J.

Get full text

Prospective biomarker study in advanced RAS wild-type colorectal cancer: POSIBA trial by García Albéniz, X, Alonso, V, Escudero, P, Méndez, M, Gallego Plazas, J, Rodriguez, J R, Salud Salvia, A, Fernández-Plana, J, Manzano Alemany, H, Zanui, M, Falcó, E, Feliu Batlle, J, Gil-Raga, M, Fernández-Martos, C, Bohn Sarmiento, U, Alonso López, M C, Calderero Aragón, V, Rojo, F, Cuatrecasas, M, Maurel, J

Get full text

Sweet's syndrome associated with norfloxacin in a prostate cancer patient by Aguiar-Bujanda, D, Aguiar-Morales, J, Bohn-Sarmiento, U

Get full text

Primary duodenal follicular lymphoma successfully treated with rituximab by Aguiar-Bujanda, D, Quiñones-Morales, I, Camacho-Galán, R, Llorca-Martínez, I, Rivero-Vera, J C, Bohn-Sarmiento, U, Aguiar-Morales, J

“…Non-Hodgkin's lymphoma (NHL) of the gastrointestinal (GI) tract is the most common extranodal lymphoma, accounting for approximately 40% of all extranodal…”
Get full text

734P Neutrophil-lymphocyte ratio predicts survival in platinum-resistant ovarian cancer patients treated with olaparib and pegylated liposomal doxorubicin (PLD): Stratified analysis from the phase II clinical trial ROLANDO, GEICO-1601 by Fidalgo, J.A. Perez, Cortés, A., García, Y., Iglesias, M., Sarmiento, U. Bohn, García, E. Calvo, Manso, L., Santaballa, A., Oaknin, A., Redondo, A., Rubio, M.J., González-Martín, A.

Get full text

141MO Pathological response and early survival data according to TNBCtype4 classifier in operable triple-negative breast cancer (TNBC) treated with neoadjuvant carboplatin and docetaxel by Echavarria Diaz-Guardamino, I., Lopez-Tarruella Cobo, S., Del Monte-Millan, M., Alvarez, E., Jerez, Y., Moreno Anton, F., García Saenz, J.Á., Massarrah, T., Ocaña, I., Cebollero, M., Ballesteros Garcia, A.I., Bohn Sarmiento, U., Gomez, H., Fuentes, H.A., Herrero Lopez, B., Gamez Casado, S., Bueno, O., Jiménez-Santos, M.J., Roche-Molina, M., Martin Jimenez, M.

Get full text

832P GEICO1601-ROLANDO trial: A multicentric single arm phase II clinical trial to evaluate the combination of olaparib and pegylated liposomal doxorubicin for platinum-resistant ovarian cancer by Perez Fidalgo, J.A., Cortés, A., García, Y., Iglesias, M., Bohn Sarmiento, U., Calvo García, E., Manso Sánchez, L., Santaballa, A., Oaknin, A., Redondo, A., Rubio, M.J., González Martín, A.

Get full text

486PProspective biomarker study in advanced RAS wild-type colorectal cancer: POSIBA trial by García Albéniz, X, Alonso, V, Escudero, P, Méndez, M, Gallego Plazas, J, Rodriguez, J R, Salud Salvia, A, Fernández-Plana, J, Manzano Alemany, H, Zanui, M, Falcó, E, Feliu Batlle, J, Gil-Raga, M, Fernández-Martos, C, Bohn Sarmiento, U, Alonso López, M C, Calderero Aragón, V, Rojo, F, Cuatrecasas, M, Maurel, J

Get full text

Pathological response in a triple-negative breast cancer cohort treated with neoadjuvant carboplatin and docetaxel according to Lehmann’s refined classification (TNBCtype-4) by Echavarria Diaz-Guardamino, I., Picornell, A.C., López-Tarruella, S., Jerez, Y., Hoadley, K., Alvarez, E., del Monte-Millán, M., Gayarre, J., Ramos-Medina, R., Massarrah, T., Ocaña, I., Cebollero, M., Moreno Antón, F., García-Saenz, J.A., Gomez Moreno, H., Fuentes, H., Ballesteros Garcia, A.I., Bohn Sarmiento, U., Perou, C., Martin Jimenez, M.

Get full text

216P Relationship between regulatory T lymphocytes (Treg): Related genes and pathological response to neoadjuvant docetaxel-carboplatin in early-stage triple-negative breast cancer (TNBC) by Martín Lozano, R., Roche-Molina, M., Alvarez, E., Del Monte-Millan, M., Jerez Gilarranz, Y., Moreno Anton, F., García Saenz, J.Á., Echavarria Diaz-Guardamino, I., Massarrah, T., Cebollero, M., Ballesteros Garcia, A.I., Bohn Sarmiento, U., Gomez Moreno, H.L., Fuentes, H.A., Herrero Lopez, B., Gamez Casado, S., Bueno Muiño, C., Bueno, O., Lopez-Tarruella Cobo, S., Martin Jimenez, M.

Get full text

Prospective evaluation of BRAF, PI3K and PTEN as predictive and prognostic biomarkers in first-line advanced KRAS wild-type colorectal cancer treated with FOLFOX or FOLFIRI plus bi-weekly cetuximab. GEMCAD 10-02 by Alonso, V., Emperador, P. Escudero, Urena, M. Mendez, Gallego, J., Rodriguez, J.R., Fernández, J., Salud, A., Falcó, E., Manzano, H., Zanui, M., Gil, M., Sarmiento, U. Bohn, Martos, C. Fernández, Calderero, V., Ferrer, A.I., Cuatrecasas, M., Rojo, F., Feliu, J., Maurel, J., García-Albéniz, X.

Get full text

Clinical activity of rituximab with either CHOP or CVP in MALT lymphoma by Aguiar Bujanda, D., Bohn Sarmiento, U., Saura Grau, S., Rodriguez Franco, C., Aguiar Morales, J.

“…Abstract only e19530 Background: Optimal management of MALT lymphoma remains undeffined. Rituximab has been proven to be an active agent in the treatment of…”
Get full text

Male breast cancer retrospective institution review of a 17-year period by Rodriguez Franco, C., Aguiar Bujanda, D., Saura Grau, S., Bohn Sarmiento, U., Aguiar Morales, J.

“…Abstract only e11638 Background: Male breast cancer (MBC) is a very uncommon illness relative to female breast cancer (FBC) The are some differences between…”
Get full text

Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment of primary gastrointestinal B- cell lymphoma by Aguiar Bujanda, D., Cabrera Suárez, M. Á., Llorca Martínez, I., Bohn Sarmiento, U., Saura Grau, S., Rodriguez Franco, C., Aguiar Morales, J.

“…Abstract only…”
Get full text

Bronquiolitis obliterante con neumonía organizada secundaria a quimioterapia by Aguiar Bujanda, D, Aguiar Morales, J, Bohn Sarmiento, U

Get full text

Central nervous system listeriosis confused with leptomeningeal carcinomatosis in cancer patients by Aguiar-Bujanda, David, Aguiar-Morales, Jose, Bohn-Sarmiento, Uriel

Get full text

Primary cutaneous marginal zone B-cell lymphoma (PCMZL-MALT) by Bohn-Sarmiento, U, Aguiar-Bujanda, D, Aguiar-Morales, J, Cabrera-Suárez, M A

Get full text

Bronchiolitis Obliterans Organizing Pneumonia Induced by Chemotherapy by Aguiar Bujanda, D., Aguiar Morales, J., Bohn Sarmiento, U.

Get full text